Molecular mechanism of doxorubicin-induced cardiomyopathy – An update

Ajay, 2010, Coronary heart disease in Indians: implications of the INTERHEART study, Indian J. Med. Res., 132, 561 Akolkar, 2015, The role of renin-angiotensin system antagonists in the prevention of doxorubicin and trastuzumab-induced cardiotoxicity, Cardiovasc. Ultrasound, 13, 18, 10.1186/s12947-015-0011-x Alexieva, 2014, Insights into mechanisms of doxorubicin cardiotoxicity, J. Phys. Pharm. Adv., 4, 342 An, 2017, UVRAG deficiency exacerbates doxorubicin-induced cardiotoxicity, Sci. Rep., 7 Andrieu-abadie, 1999, L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: the role of inhibition of ceramide generation, FASEB J., 13, 1501, 10.1096/fasebj.13.12.1501 Arai, 1998, Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits, J. Mol. Cell. Cardiol., 30, 243, 10.1006/jmcc.1997.0588 Aries, 2004, Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity, Proc. Natl. Acad. Sci. USA, 101, 6975, 10.1073/pnas.0401833101 Arola, 2000, Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis, Cancer Res., 60, 1789 Arunachalam, 2012, Adriamycin inhibits adipogenesis through the modulation of PPARγ and restoration of adriamycin-mediated inhibition of adipogenesis by PPARγ over-expression, Toxicol. Mech. Methods, 22, 540, 10.3109/15376516.2012.692110 Arunachalam, 2013, Doxorubicin treatment inhibits PPARγ and may induce lipotoxicity by mimicking a type 2 diabetes-like condition in rodent models, FEBS Lett., 587, 105, 10.1016/j.febslet.2012.11.019 Ascensão, 2005, Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis, Am. J. Physiol. Heart Circ. Physiol., 289, H722, 10.1152/ajpheart.01249.2004 Asrih, 2013, Emerging role of epigenetics and miRNA in diabetic cardiomyopathy, Cardiovasc. Pathol., 22, 117, 10.1016/j.carpath.2012.07.004 Bahadır, 2014, The role of nitric oxide in doxorubicin-induced cardiotoxicity: experimental study, Turk. J. Haematol., 31, 68, 10.4274/Tjh.2012.0013 Bartlett, 2017, Autophagic dysregulation in doxorubicin cardiomyopathy, J. Mol. Cell. Cardiol., 104, 1, 10.1016/j.yjmcc.2017.01.007 Bayeva, 2013, Taking diabetes to heart—deregulation of myocardial lipid metabolism in diabetic cardiomyopathy, J. Am. Heart Assoc., 2, e000433, 10.1161/JAHA.113.000433 Berthiaume, 2007, Adriamycin-induced oxidative mitochondrial cardiotoxicity, Cell Biol. Toxicol., 23, 15, 10.1007/s10565-006-0140-y Berthiaume, 2007, Persistent alterations in the gene expression profile of the heart subsequent to chronic doxorubicin treatment, Cardiovasc. Toxicol. Cardiovasc. Toxicol., 7, 178, 10.1007/s12012-007-0026-0 Bian, 2009, Neuregulin-1 attenuated the doxorubicin-induced decrease in cardiac troponins, Am. J. Physiol. Heart Circ. Physiol., 297, H1974, 10.1152/ajpheart.01010.2008 Billingham, 1978, Anthracycline cardiomyopathy monitored by morphologic changes, Cancer Treat. Rep., 62, 865 Boudina, 2007, Mitochondrial energetics in the heart in obesity-related diabetes direct evidence for increased uncoupled respiration and activation of uncoupling proteins, Diabetes, 56, 2457, 10.2337/db07-0481 Bristow, 1981, Dose-effect and structure-function relationships in doxorubicin cardiomyopathy, Am. Heart J., 102, 709, 10.1016/0002-8703(81)90096-X Bristow, 1980, Acute and chronic cardiovascular effects of doxorubicin in the dog: the cardiovascular pharmacology of drug-induced histamine release, J. Cardiovasc. Pharmacol., 2, 487, 10.1097/00005344-198009000-00002 Bruch, 1983, Differential effect of lipid peroxidation on membrane fluidity as determined by electron spin resonance probes, Biochim. Biophys. Acta, 733, 216, 10.1016/0005-2736(83)90525-4 Pereira, 2011, Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol, Curr. Pharm. Des., 17, 2113, 10.2174/138161211796904812 Calderone, 1991, Adriamycin-induced changes to the myocardial beta-adrenergic system in the rabbit, J. Mol. Cell. Cardiol., 23, 333, 10.1016/0022-2828(91)90069-X Campisi, 2005, Senescent cells, tumour suppression, and organismal ageing: good citizens, bad neighbours, Cell, 120, 513, 10.1016/j.cell.2005.02.003 Cardoso, 2008, Doxorubicin increases the susceptibility of brain mitochondria to Ca 2+-induced permeability transition and oxidative damage, Free Radic. Biol. Med., 45, 1395, 10.1016/j.freeradbiomed.2008.08.008 Caroni, 1981, The cardiotoxic antibiotic doxorubicin inhibits the Na+/Ca2+ exchange of dog heart sarcolemmal vesicles, FEBS Lett., 130, 184, 10.1016/0014-5793(81)81115-5 Carvalho, 2014, Doxorubicin‐induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy, Med. Res. Rev., 34, 106, 10.1002/med.21280 Chatterjee, 2010, Doxorubicin cardiomyopathy, Cardiology, 115, 155, 10.1159/000265166 Chau, 2002, Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation, Oncogene, 21, 8817, 10.1038/sj.onc.1206032 Chen, 2008, Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure, Proc. Natl. Acad. Sci. USA, 105, 2111, 10.1073/pnas.0710228105 Chen, 1999, Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes, Hypertension, 34, 1223, 10.1161/01.HYP.34.6.1223 Cheung, 2015, Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes, J. Biol. Chem., 290, 10981, 10.1074/jbc.M114.607960 Chichuk, 1998, Free radical mechanisms of low-intensive laser radiation, Vestn. Ross. Akad. Med. Nauk., 27 Childs, 2002, Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2: Bax ratio, Cancer Res., 62, 4592 Chua, 2006, Multiple actions of pifithrin-α on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells, Am. J. Physiol. Heart Circ. Physiol., 290, H2606, 10.1152/ajpheart.01138.2005 D'Anglemont De Tassigny, 2004, Volume‐sensitive chloride channels (ICl, vol) mediate doxorubicin‐induced apoptosis through apoptotic volume decrease in cardiomyocytes, Clin. Pharmacol., 18, 531 Damiani, 2016, Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone, Arch. Toxicol., 90, 2063, 10.1007/s00204-016-1759-y Davies, 1986, Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase, J. Biol. Chem., 261, 3060, 10.1016/S0021-9258(17)35746-0 Davies, 1983, Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5-iminodaunorubicin, FEBS Lett., 153, 227, 10.1016/0014-5793(83)80153-7 De Angelis, 2015, SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells, Int. J. Cardiol., 189, 30, 10.1016/j.ijcard.2015.03.438 De Angelis, 2016, Doxorubicin cardiotoxicity and target cells: a broader perspective, Cardio-Oncology, 2, 2, 10.1186/s40959-016-0012-4 Doroshow, 1986, Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical, J. Biol. Chem., 261, 3068, 10.1016/S0021-9258(17)35747-2 Doroshow, 1979, The effect of doxorubicin on hepatic and cardiac glutathione, Res. Commun. Chem. Pathol. Pharmacol., 26, 285 Doroshow, 1980, Enzymatic defences of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin, J. Clin. Investig., 65, 128, 10.1172/JCI109642 Dorr, 1996, Cytoprotective agents for anthracyclines, Semin. Oncol., 22, 23 Duncan, 2011, Mitochondrial dysfunction in diabetic cardiomyopathy, Biochim. Biophys. Acta, 1813, 1351, 10.1016/j.bbamcr.2011.01.014 Ehrke, 1984, Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture, Cancer Res., 44, 2497 Engelman, 2007, MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalling, Science, 316, 1039, 10.1126/science.1141478 Eom, 2005, Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype, Oncogene, 24, 4765, 10.1038/sj.onc.1208627 Erickson, 2013, Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation, Nature, 502, 372, 10.1038/nature12537 Fogli, 2004, The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage, FASEB J., 18, 664, 10.1096/fj.03-0724rev Frantz, 2001, Role of TLR-2 in the activation of nuclear factor κB by oxidative stress in cardiac myocytes, J. Biol. Chem., 276, 5197, 10.1074/jbc.M009160200 Freude, 2000, Apoptosis is initiated by myocardial ischemia and executed during reperfusion, J. Mol. Cell. Cardiol., 32, 197, 10.1006/jmcc.1999.1066 Fridovich, 1995, Superoxide radical and superoxide dismutases, Annu. Rev. Biochem., 64, 97, 10.1146/annurev.bi.64.070195.000525 Gabrielson, 2007, Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury, Cancer Res., 67, 1436, 10.1158/0008-5472.CAN-06-3721 Garcı́a, 1997, Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation, FEBS Lett., 408, 297, 10.1016/S0014-5793(97)00447-X Gewirtz, 1999, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochem. Pharmacol., 57, 727, 10.1016/S0006-2952(98)00307-4 Gilleron, 2009, NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis, Biochem. Biophys. Res. Commun., 388, 727, 10.1016/j.bbrc.2009.08.085 Goetzenich, 2009, Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig, J. Heart Lung Transplant., 28, 1087, 10.1016/j.healun.2009.06.025 Goffart, 2004, Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy, Cardiovasc. Res., 64, 198, 10.1016/j.cardiores.2004.06.030 Goormaghtigh, 1980, Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity, Biochem. Pharmacol., 29, 3003, 10.1016/0006-2952(80)90050-7 Gottar-Guillier, 2011, The tyrosine kinase BMX is an essential mediator of inflammatory arthritis in a kinase-independent manner, J. Immunol., 186, 6014, 10.4049/jimmunol.1002813 Gratia, 2012, Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress, Cardiovasc. Res., 95, 290, 10.1093/cvr/cvs134 Grimmond, 1982, Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide, Biochem. Pharmacol., 31, 3379, 10.1016/0006-2952(82)90615-3 Gu, 2012, Increased expression of integrin-linked kinase improves cardiac function and decreases mortality in dilated cardiomyopathy model of rats, PLoS One, 7, e31279, 10.1371/journal.pone.0031279 Guerra, 1999, Myocyte death in the failing human heart is gender dependent, Circ. Res., 85, 856, 10.1161/01.RES.85.9.856 Guo, 2013, Hydrogen sulphide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells, Int. J. Mol. Med., 31, 644, 10.3892/ijmm.2013.1246 Guo, 2013, Exogenous hydrogen sulphide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells, Cell Physiol. Biochem., 32, 1668, 10.1159/000356602 Haskill, 1981, Adriamycin-activated macrophages as tumour growth inhibitors, Cancer Res., 41, 3852 Hiroyuki, 1984, Formation of age pigment-like fluorescent substances during peroxidation of lipids in model membranes, Biochim. Biophys. Acta, 792, 123, 10.1016/0005-2760(84)90212-1 Holopainen, 2015, Endothelial Bmx tyrosine kinase activity is essential for myocardial hypertrophy and remodelling, Proc. Natl. Acad. Sci. USA, 112, 13063, 10.1073/pnas.1517810112 Hong, 2002, Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine, Pediatr. Res., 51, 249, 10.1203/00006450-200202000-00020 Horie, 2010, Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway, Cardiovasc. Res., cvq148 How, 2006, Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice, Diabetes, 55, 466, 10.2337/diabetes.55.02.06.db05-1164 Huang, 2010, Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice, Circulation, 121, 675, 10.1161/CIRCULATIONAHA.109.902221 Ichikawa, 2014, Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation, J. Clin. Investig., 124, 617, 10.1172/JCI72931 Idris-Khodja, 2013, Grape-derived polyphenols prevent doxorubicin-induced blunted EDH-mediated relaxations in the rat mesenteric artery: role of ROS and angiotensin II, Evid. Based Complement. Altern. Med., 2013, 516017, 10.1155/2013/516017 Iliskovic, 1997, Lipid-lowering: an important factor in preventing adriamycin-induced heart failure, Am. J. Pathol., 150, 727 Iwasaki, 1991, Ultrastructural alterations of the myocardium induced by doxorubicin, Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 60, 35, 10.1007/BF02899525 Jang, 2004, Doxorubicin treatment in vivo activates caspase‐12 mediated cardiac apoptosis in both male and female rats, FEBS Lett., 577, 483, 10.1016/j.febslet.2004.10.053 Jean, 2015, Mitochondrial targeting of doxorubicin eliminates nuclear effects associated with cardiotoxicity, ACS Chem. Biol., 10, 2007, 10.1021/acschembio.5b00268 Jeyaseelan, 1997, Molecular mechanisms of doxorubicin-induced cardiomyopathy selective suppression of Rieske iron-sulphur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes, J. Biol. Chem., 272, 5828, 10.1074/jbc.272.9.5828 Jones, 1990, Adriamycin cardiomyopathy in the rabbit: alterations in contractile proteins and myocyte function, Cardiovasc. Res., 24, 834, 10.1093/cvr/24.10.834 Jungsuwadee, 2016, Doxorubicin-induced cardiomyopathy: an update beyond oxidative stress and myocardial cell death, Cardiovasc. Regen. Med., 3, e1127 Katamura, 2014, Curcumin attenuates doxorubicin-induced cardiotoxicity by inducing autophagy via the regulation of JNK phosphorylation, J. Clin. Exp. Cardiol., 5, 337, 10.4172/2155-9880.1000337 Kawada, 2000, Chronic adriamycin treatment impairs myocardial interstitial neuronal release of norepinephrine and epinephrine, J. Cardiovasc. Pharmacol., 36, S31, 10.1097/00005344-200000006-00008 Kawaguchi, 2012, Prior starvation mitigates acute doxorubicin cardiotoxicity through the restoration of autophagy in affected cardiomyocytes, Cardiovasc. Res., cvs282 Kawamura, 2004, Expression of p300 protects cardiac myocytes from apoptosis in vivo, Biochem. Biophys. Res. Commun., 315, 733, 10.1016/j.bbrc.2004.01.105 Kim, 2006, Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity, Eur. J. Pharmacol., 541, 24, 10.1016/j.ejphar.2006.04.045 Kim, 2006, Doxorubicin-induced reactive oxygen species generation and intracellular Ca 2+ increase are reciprocally modulated in rat cardiomyocytes, Exp. Mol. Med., 38, 535, 10.1038/emm.2006.63 Kim, 2003, Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis, Mol. Pharmacol., 63, 368, 10.1124/mol.63.2.368 Kobayashi, 2012, Suppression of autophagy is protective in high glucose-induced cardiomyocyte injury, Autophagy, 8, 577, 10.4161/auto.18980 Koenig, 1997, Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation, Wien. Klin. Wochenschr., 109, 13 Kuznetsov, 2011, Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death, Biochim. Biophys. Acta, 1813, 1144, 10.1016/j.bbamcr.2011.03.002 Kwok, 2002, Unexpected anthracycline-mediated alterations in iron-regulatory protein-RNA-binding activity: the iron and copper complexes of anthracyclines decrease RNA-binding activity, Mol. Pharmacol., 62, 888, 10.1124/mol.62.4.888 L'Ecuyer, 2006, DNA damage is an early event in doxorubicin-induced cardiac myocyte death, Am. J. Physiol. Heart Circ. Physiol., 291, H1273, 10.1152/ajpheart.00738.2005 Lakshmanan, 2013, The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signalling proteins, Int. J. Biochem. Cell Biol., 45, 438, 10.1016/j.biocel.2012.09.017 Li, 2014, Cardiomyocyte autophagy and cancer chemotherapy, J. Mol. Cell. Cardiol., 71, 54, 10.1016/j.yjmcc.2013.11.007 Li, 2014, Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction, Oxid. Med. Cell. Longev., 2014, 748524, 10.1155/2014/748524 Li, 2002, Early changes in myocardial antioxidant enzymes in rats treated with adriamycin, Mol. Cell. Biochem., 232, 19, 10.1023/A:1014862912783 Li, 1995, Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase, Nat. Genet., 11, 376, 10.1038/ng1295-376 Li, 2007, Involvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic rats, J. Clin. Biochem. Nutr., 41, 58, 10.3164/jcbn.2007008 Liu, 2005, Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure, Am. J. Physiol. Heart Circ. Physiol., 289, H660, 10.1152/ajpheart.00268.2005 Liu, 2008, ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes, Am. J. Physiol. Heart Circ. Physiol., 295, H1956, 10.1152/ajpheart.00407.2008 Liu, 2004, Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice, Am. J. Physiol. Heart Circ. Physiol., 286, H933, 10.1152/ajpheart.00759.2003 LoConte, 2008, A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer, Cancer Chemother. Pharmacol., 63, 109, 10.1007/s00280-008-0719-5 Luo, 2013, Diabetes increases mortality after myocardial infarction by oxidizing CaMKII, J. Clin. Investig., 123, 1262, 10.1172/JCI65268 Maccubbin, 1992, Adriamycin-induced modulation of host defences in tumour-bearing mice, Cancer Res., 52, 3572 Maejima, 2008, Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage, Aging Cell., 7, 125, 10.1111/j.1474-9726.2007.00358.x Markin, 1996, Lipid peroxidation and activity of diagnostically significant enzymes in cosmonauts after flights of various durations, Aviakosm Ekol. Med., 31, 14 Mazumder, 2004, Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts, Diabetes, 53, 2366, 10.2337/diabetes.53.9.2366 Minotti, 2004, Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity, Pharmacol. Rev., 56, 185, 10.1124/pr.56.2.6 Minotti, 2001, Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes, Cancer Res., 61, 8422 Miranda, 2003, Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin, Blood, 102, 2574, 10.1182/blood-2003-03-0869 Mitchell-Jordan, 2008, Loss of Bmx nonreceptor tyrosine kinase prevents pressure overload-induced cardiac hypertrophy, Circ. Res., 103, 1359, 10.1161/CIRCRESAHA.108.186577 Mitry, 2016, Doxorubicin-induced heart failure: phenotype and molecular mechanisms, Int. J. Cardiol. Heart Vasc., 10, 17 Moriyama, 2010, Involvement of advanced glycation end-products, pentosidine and N ɛ-(carboxymethyl) lysine, in doxorubicin-induced cardiomyopathy in rats, Toxicology, 268, 89, 10.1016/j.tox.2009.12.004 Muhammed, 1983, Inhibition of mitochondrial oxidative phosphorylation by adriamycin, Biochim. Biophys. Acta, 722, 43, 10.1016/0005-2728(83)90155-X Myers, 1983, A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine, Semin. Oncol., 10, 53 Neri, 1991, Anthracycline cardiotoxicity: in vivo and in vitro effects on biochemical parameters and heart ultrastructure of the rat, Oncology, 48, 327, 10.1159/000226952 Nordgren, 2014, Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts, Toxicol. Appl. Pharmacol., 274, 107, 10.1016/j.taap.2013.10.023 Octavia, 2012, Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies, J. Mol. Cell. Cardiol., 52, 1213, 10.1016/j.yjmcc.2012.03.006 Oliveira, 2014, Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells, Toxicol. Lett., 224, 380, 10.1016/j.toxlet.2013.11.023 Olson, 1990, Doxorubicin cardiotoxicity: analysis of prevailing hypotheses, FASEB J., 4, 3076, 10.1096/fasebj.4.13.2210154 Ondrias, 1990, Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle, Circ. Res., 67, 1167, 10.1161/01.RES.67.5.1167 Outomuro, 2007, Adriamycin-induced myocardial toxicity: new solutions for an old problem?, Int. J. Cardiol., 117, 6, 10.1016/j.ijcard.2006.05.005 Pani, 2000, Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells, Cancer Res., 60, 4654 Papadopoulou, 1999, Structural and functional impairment of mitochondria in adriamycin-induced cardiomyopathy in mice: suppression of cytochrome c oxidase II gene expression, Biochem. Pharmacol., 57, 481, 10.1016/S0006-2952(98)00305-0 Park, 2010, Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart, Cardiovasc. Res., cvq361 Parker, 2001, Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers, Biochim. Biophys. Acta, 1514, 206, 10.1016/S0005-2736(01)00371-6 Pecoraro, 2015, Doxorubicin-mediated cardiotoxicity: role of mitochondrial connexin 43, Cardiovasc. Toxicol., 1 Pelikan, 1986, Acute doxorubicin cardiotoxicity: functional, metabolic, and morphologic alterations in the isolated, perfused rat heart, J. Cardiovasc. Pharmacol., 8, 1058, 10.1097/00005344-198609000-00026 Pereira, 2013, Inducible overexpression of GLUT1 prevents mitochondrial dysfunction and attenuates structural remodelling in pressure overload but does not prevent left ventricular dysfunction, J. Am. Heart Assoc., 2, e000301, 10.1161/JAHA.113.000301 Piantadosi, 2008, Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1, Circ. Res., 103, 1232, 10.1161/01.RES.0000338597.71702.ad Piegari, 2013, Doxorubicin induces senescence and impairs function of human cardiac progenitor cells, Basic Res. Cardiol., 108, 334, 10.1007/s00395-013-0334-4 Pointon, 2010, Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activations, PLoS One, 5, e12733, 10.1371/journal.pone.0012733 Poizat, 2005, Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells, Mol. Cell. Biol., 25, 2673, 10.1128/MCB.25.7.2673-2687.2005 Praet, 1993, In-vivo and in-vitro mitochondrial membrane damages induced in mice by adriamycin and derivatives, Biochim. Biophys. Acta, 1149, 79, 10.1016/0005-2736(93)90027-W Ranek, 2009, Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy, Curr. Hypertens. Rep., 11, 389, 10.1007/s11906-009-0068-8 Riad, 2008, Toll‐like receptor‐4 deficiency attenuates doxorubicin‐induced cardiomyopathy in mice, Eur. J. Heart Fail., 10, 233, 10.1016/j.ejheart.2008.01.004 Riad, 2009, Pretreatment with statin attenuates the cardiotoxicity of Doxorubicin in mice, Cancer Res., 69, 695, 10.1158/0008-5472.CAN-08-3076 Roca-Alonso, 2012, Breast cancer treatment and adverse cardiac events: what are the molecular mechanisms?, Cardiology, 122, 253, 10.1159/000339858 Rubinstein, 2012, Life in the balance–a mechanistic view of the crosstalk between autophagy and apoptosis, J. Cell Sci., 125, 5259, 10.1242/jcs.115865 Sacco, 2009, ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat, Vasc. Pharmacol., 50, 166, 10.1016/j.vph.2009.01.001 Sam, 2000, Progressive left ventricular remodelling and apoptosis late after myocardial infarction in mouse heart, Am. J. Physiol. Heart Circ. Physiol., 279, H422, 10.1152/ajpheart.2000.279.1.H422 Sardão, 2009, Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets, Cell Biol. Toxicol., 25, 227, 10.1007/s10565-008-9070-1 Sarvazyan, 1996, Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes, Am. J. Physiol., 271, H2079 Sauter, 2011, Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome: progress at a snail's pace, Cancer Biol. Ther., 11, 1008, 10.4161/cbt.11.12.15540 Sawyer, 2002, Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1β and anti-erbB2, Circulation, 105, 1551, 10.1161/01.CIR.0000013839.41224.1C Sayed-ahmed, 2000, Propionyl-L-carnitine as a potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria, Pharmacol. Res., 41, 143, 10.1006/phrs.1999.0583 Shi, 2011, Mechanisms and management of doxorubicin cardiotoxicity, Herz, 36, 296, 10.1007/s00059-011-3470-3 Singal, 2000, Adriamycin-induced heart failure: mechanisms and modulation, Mol. Cell. Biochem., 207, 77, 10.1023/A:1007094214460 Singal, 2000, Adriamycin-induced heart failure: mechanisms and modulation, Mol. Cell. Biochem., 207, 77, 10.1023/A:1007094214460 Singal, 1986, Adriamycin stimulates low-affinity Ca2+ binding and lipid peroxidation but depresses myocardial function, Am. J. Physiol., 250, H419 Sistigu, 2014, Cancer cell-autonomous contribution of type I interferon signalling to the efficacy of chemotherapy, Nat. Med., 20, 1301, 10.1038/nm.3708 Siveski-Iliskovic, 1995, Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect, Circulation, 91, 10, 10.1161/01.CIR.91.1.10 Smuder, 2013, Doxorubicin-induced markers of myocardial autophagic signalling in sedentary and exercise-trained animals, J. Appl. Physiol., 115, 176, 10.1152/japplphysiol.00924.2012 Solem, 1996, A dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin, J. Mol. Cell. Cardiol., 28, 1023, 10.1006/jmcc.1996.0095 Spallarossa, 2010, p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells, PLoS One, 5, e15583, 10.1371/journal.pone.0015583 Spallarossa, 2006, Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: the role of MAP kinases and NAD (P) H oxidase, Cardiovasc. Res., 69, 736, 10.1016/j.cardiores.2005.08.009 Suliman, 2007, The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy, J. Clin. Investig., 117, 3730 Suwei, 2002, Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide, Biochem. J., 367, 729, 10.1042/bj20020752 Tacar, 2013, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems, J. Pharm. Pharmacol., 65, 157, 10.1111/j.2042-7158.2012.01567.x Takemura, 2007, Doxorubicin-induced cardiomyopathy: from the cardiotoxic mechanisms to management, Prog. Cardiovasc. Dis., 49, 330, 10.1016/j.pcad.2006.10.002 Tavora, 2014, Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy, Nature, 514, 112, 10.1038/nature13541 Tea, 1999, Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats temporal regulation and spatial heterogeneity, Hypertension, 34, 229, 10.1161/01.HYP.34.2.229 Terman, 2005, Autophagy in cardiac myocyte homeostasis, ageing, and pathology, Cardiovasc. Res., 68, 355, 10.1016/j.cardiores.2005.08.014 Terman, 2008, The involvement of lysosomes in myocardial ageing and disease, Curr. Cardiol. Rev., 4, 107, 10.2174/157340308784245801 Tham, 2015, Pathophysiology of cardiac hypertrophy and heart failure: signalling pathways and novel therapeutic targets, Arch. Toxicol., 1 Tokarska-Schlattner, 2010, Early effects of doxorubicin in perfused heart: transcriptional profiling reveals inhibition of cellular stress response genes, Am. J. Physiol. Regul. Integr. Comp. Physiol., 298, R1075, 10.1152/ajpregu.00360.2009 Tokarska-Schlattner, 2005, Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply, Am. J. Physiol. Heart Circ. Physiol., 289, H37, 10.1152/ajpheart.01057.2004 Tokarska-Schlattner, 2006, New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics, J. Mol. Cell. Cardiol., 41, 389, 10.1016/j.yjmcc.2006.06.009 Tomita, 2004, Bone marrow is a source of regenerated cardiomyocytes in doxorubicin-induced cardiomyopathy and granulocyte colony-stimulating factor enhances migration of bone marrow cells and attenuates cardiotoxicity of doxorubicin under electron microscopy, J. Heart Lung Transplant., 23, 577, 10.1016/j.healun.2003.06.001 Torti, 1986, Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy, Cancer Res., 46, 3722 Trouet, 1979, Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data, Cancer Chemother. Pharmacol., 2, 77, 10.1007/BF00253110 Tsai, 2000, Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation, Mol. Cell. Biol., 20, 2043, 10.1128/MCB.20.6.2043-2054.2000 Ueno, 2006, Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo, J. Pharmacol. Sci., 101, 151, 10.1254/jphs.FP0050980 Vacchi-Suzzi, 2012, Perturbation of microRNAs in rat heart during chronic doxorubicin treatment, PLoS One, 7, e40395, 10.1371/journal.pone.0040395 Vedam, 2010, Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice, Am. J. Physiol. Heart Circ. Physiol., 298, H1832, 10.1152/ajpheart.01047.2009 Wada, 2008, Antagonistic control of cell fates by JNK and p38-MAPK signalling, Cell Death Differ., 15, 89, 10.1038/sj.cdd.4402222 Wallace, 2003, Doxorubicin‐induced cardiac mitochondrionopathy, Pharmacol. Toxicol., 93, 105, 10.1034/j.1600-0773.2003.930301.x Wallace, 2007, Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis, Cardiovasc. Toxicol., 7, 101, 10.1007/s12012-007-0008-2 Wang, 2002, Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide, Biochem. J., 367, 729, 10.1042/bj20020752 Wang, 2012, Hydrogen sulphide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress, Mol. Cell. Biochem., 363, 419, 10.1007/s11010-011-1194-6 Wu, 2016, Doxorubicin toxicity changes myocardial energy metabolism in rats, Chem. Biol. Interact., 244, 149, 10.1016/j.cbi.2015.12.010 Xie, 2009, Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation, J. Biol. Chem., 284, 5488, 10.1074/jbc.M806487200 Xu, 2009, Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection, J. Cell Mol. Med., 13, 1499, 10.1111/j.1582-4934.2009.00833.x Xu, 2001, Effects of doxorubicin on the myocardium are mediated by oxygen free radicals, Life Sci., 68, 889, 10.1016/S0024-3205(00)00990-5 Xu, 2005, Molecular pharmacology of the interaction of anthracyclines with iron, Mol. Pharmacol., 68, 261, 10.1124/mol.105.013383 Yang, 2013, Doxorubicin caused apoptosis of mesenchymal stem cells viap38, JNK and p53 pathway, Cell Physiol. Biochem., 32, 1072, 10.1159/000354507 Yasuda, 2010, Adriamycin nephropathy: a failure of endothelial progenitor cell-induced repair, Am. J. Pathol., 176, 1685, 10.2353/ajpath.2010.091071 Zelarayan, 2009, NF-κB activation is required for adaptive cardiac hypertrophy, Cardiovasc. Res., 84, 416, 10.1093/cvr/cvp237 Zhang, 2012, Identification of the molecular basis of doxorubicin-induced cardiotoxicity, Nat. Med., 18, 1639, 10.1038/nm.2919 Zhao, 2017, Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes, Sci. Rep., 7, 44735, 10.1038/srep44735 Zhou, 2001, Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin, Cancer Res., 61, 771 Zhou, 2000, Lipotoxic heart disease in obese rats: implications for human obesity, Proc. Natl. Acad. Sci. USA, 97, 1784, 10.1073/pnas.97.4.1784 Zhu, 2010, Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity, Eur. J. Pharmacol., 643, 247, 10.1016/j.ejphar.2010.06.024 Zordoky, 2011, Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver, Drug Metab. Dispos., 39, 1440, 10.1124/dmd.111.039123